Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts
In the Original Investigation titled “Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial,”^1^ published July 25, 2023, the 13th author’s degree was incorrect in the byline. Her degree was listed as MD; however, the highest degree that she had earned in 2023 was an honours bachelor of science (HBSc). This article has been corrected.^1^
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1García-Pardo M, Czarnecka-Kujawa K, Law JH, et al. Association of circulating tumor DNA testing before tissue diagnosis with time to treatment among patients with suspected advanced lung cancer: the ACCELERATE nonrandomized clinical trial. JAMA Netw Open. 2023;6(7):e 2325332. doi:10.1001/jamanetworkopen.2023.2533237490292 PMC 10369925 · doi ↗ · pubmed ↗